Efficacy of Once Daily Gastroretentive Gabapentin (Gralise) in the Treatment of Post Amputation Pain
Status: Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 06 Sep 2019
Price : $35 *
At a glance
- Drugs Gabapentin (Primary)
- Indications Phantom limb pain
- Focus Therapeutic Use
- 13 Sep 2017 Planned End Date changed from 1 May 2017 to 1 Dec 2018.
- 13 Sep 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Nov 2018.
- 13 Sep 2017 Status changed from recruiting to active, no longer recruiting.